Counselors in Shell Lake, WI Accepting Medicare
9 Counselors found. Showing 1 - 9
 Andrew Schulz, QTT Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 E County Highway B, Shell Lake, WI 54871 Phone: 715-468-2841 |
 Wendy Muska Counselor Medicare: Not Enrolled in Medicare Practice Location: 800 E County Hwy B, Shell Lake, WI 54871 Phone: 715-468-2841 |
Mary Ellen Anderson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 246 Industrial Blvd, Shell Lake, WI 54871 Phone: 715-468-2841 |
Matthew Michael Meyer, M.A. LPC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 E County Hwy B, Shell Lake, WI 54871 Phone: 715-468-2841 |
Brian Nord Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 246 Industrial Blvd, Shell Lake, WI 54871 Phone: 715-468-2841 Fax: 715-468-2374 |
Cathy Marie Ekern, LPC MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 246 Industrial Blvd, Shell Lake, WI 54871 Phone: 715-468-2841 |
Delores Henderson-olson, BS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 11 Fifth Ave, Shell Lake, WI 54871 Phone: 715-468-2841 Fax: 715-468-2374 |
Alexa Evon Demoe, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 246 Industrial Blvd, Shell Lake, WI 54871 Phone: 715-468-2841 |
Amber Miller Counselor Medicare: Not Enrolled in Medicare Practice Location: 600 E County Hwy B, Shell Lake, WI 54871 Phone: 715-468-2841 |
News Archive
Highly concentrated solution of chemical messengers could block male to female HIV transmission
Researchers in the U.S have shown that it may be possible to block the transmission of the HIV virus from a man to a woman by using a highly concentrated solution of chemical messengers that attract white blood cells to the site of infection.
Impax initiates challenge of patent listed by Shionogi Pharma concerning Fenoglide
Impax Laboratories, Inc. today confirms that it has initiated a challenge of a patent listed by Shionogi Pharma, Inc. in connection with its Fenoglide® (fenofibrate) tablets, 40 and 120 mg.
New approach could lead to devising alternative tools for cancer therapy
Inducing biological tissue damage with an atmospheric pressure plasma source could open the door to many applications in medicine
AMRI extends and expands research collaboration with CHDI Foundation
AMRI announced today the five year extension and expansion of its ongoing research collaboration with CHDI Foundation, Inc. (CHDI), focused on the discovery of new therapeutic agents for the treatment of Huntington's disease (HD).
› Verified 8 days ago